Mirum Pharmaceuticals logo
Mirum Pharmaceuticals
MIRM | NASDAQ
Chart Builder DCF Calculator
$91.58
-$2.41 (-2.56%)
At close: Nov 16, 2026, 4:00 PM ET
$91.58
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Mirum Pharmaceuticals Company Profile

Company profile explained

Company Profile

Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.

Key Executives

Name Position
Christopher Peetz Chief Executive Officer & Director
Douglas T. Sheehy Chief Legal Officer & Secretary
Eric H. Bjerkholt Chief Financial Officer
Erin Campany Chief People Officer
Peter Radovich Chief Operating Officer & President
Andrew McKibben Senior Vice President, Strategic Finance & Investor Relations
Jean-Luc Girardet Chief Technical Officer
Joanne J. Quan Chief Medical Officer
Lara Longpre Chief Development Officer
Meredith Kiernan Senior Director of Global Corporate Communications
Vinita Kumar Senior Vice President of Quality

Latest SEC Filings

Date Type Title
Oct 26, 2026 8-K Current Report
Oct 19, 2026 4 Filing
Oct 14, 2026 4 Filing
Oct 13, 2026 8-K Current Report
Oct 06, 2026 4 Filing
Sep 28, 2026 8-K Current Report
Sep 22, 2026 3 Filing
Sep 15, 2026 4 Filing
Sep 08, 2026 8-K Current Report
Sep 03, 2026 4 Filing
View All SEC Filings ➞
Mirum Pharmaceuticals
Mirum Pharmaceuticals logo
Country United States
IPO Date Jul 18, 2019
Industry Biotechnology
Sector Healthcare
Employees 433
CEO Christopher Peetz

Contact Details

989 East Hillsdale Boulevard Foster City, California 94404 United States

Stock Details

Ticker Symbol MIRM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001759425
CUSIP Number 604749101
ISIN Number US6047491013
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.